In much the same way people can “chat” with large language models like GPT-4, Stanford Health Care clinicians can now interact with a patient’s medical records through an AI-backed software called ChatEHR.
New test improves quality control of allergy therapeutics
An interdisciplinary research team from the Allergology and Veterinary Medicine Divisions at the Paul-Ehrlich-Institut (PEI) has developed a novel laboratory test that enables the determination of adjuvanted allergoids in finished medicinal products. Content analyses of finished medicinal products were not possible in the past due to the complex structure of this medicinal product group, which contains both adjuvants and allergoids (chemically modified allergens) and therefore had to be performed on an intermediary production step.
How the brain distinguishes between ambiguous hypotheses
When navigating a place that we’re only somewhat familiar with, we often rely on unique landmarks to help make our way. However, if we’re looking for an office in a brick building, and there are many brick buildings along our route, we might use a rule like looking for the second building on a street, rather than relying on distinguishing the building itself.
Disadvantaged backgrounds can leave a lifelong accelerated aging marker in children
Economic disadvantage leaves a biological imprint on children which could last throughout their lifetime, reducing their quality and length of life. These are the findings of a study of more than 1,000 European children led by researchers at Imperial College London. The research finds evidence that the impacts of socioeconomic status can be seen in the blood cells of children, with those from less privileged backgrounds having shorter telomeres—an established biomarker for aging.
Obesity linked to subsequent neoplasms in childhood cancer survivors
Body mass index (BMI) and physical activity are associated with the risk for subsequent neoplasms among childhood cancer survivors, according to a study published online June 5 in JAMA Oncology.
Blood test shows 95% accuracy for Alzheimer’s disease diagnosis in outpatient memory clinics
Alzheimer’s disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones. With new treatments available for people with early signs of Alzheimer’s disease, there is a growing need for accessible and cost-effective tests to diagnose Alzheimer’s disease sooner.
Japanese walking: The benefits of this fitness trend
A fitness trend known as Japanese walking is capturing attention online, promising major health benefits with minimal equipment and time.
Silent struggles of post-9/11 veterans linked to rising suicides
Post-9/11 veterans often face visible challenges like finding gainful employment or recovering from physical injuries, but some of their struggles are invisible. Veterans may carry a sense of isolation and the painful belief that their presence is a burden to those around them. When these thoughts persist over time, they could contribute to an increased risk of suicide, according to a new study by researchers at the Clearinghouse for Military Family Readiness at Penn State (Clearinghouse).
Aphantasia might be linked to alterations in brain connectivity
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA’s neuroimaging center, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, published in Cortex, pave the way for a better understanding of this fascinating cognitive ability, which some of us entirely lack.
AI-powered tool set to transform type 1 diabetes diagnosis and treatment
Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of developing type 1 diabetes (T1D) and predict treatment responses, potentially changing how the disease is diagnosed and managed.